Riskpilot← Back to searchSign inGet full accessAugmedica Nordic AB
ABActiveOrg 5590573084Kvistrumsvägen 6Computer programming activities · NACE 6210Est. 20160 employees
Revenue 2025
SEK 16K
-29% vs 2024
EBITDA margin
-372.2%
-60% vs 2024
Equity ratio
90.8%
Financial strength
Net profit 2025
SEK 8K
+228% vs 2024
| Revenue | SEK 16K | -29% |
| EBITDA | SEK -60K | -60% |
| Net profit | SEK 8K | +228% |
| Total assets | SEK 758K | -22% |
| Equity | SEK 688K | +1% |
| Employees | 0 | — |
Legal name
Augmedica Nordic AB
Org number
5590573084
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
4 april 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall tillhandahålla medicinsk kompetens i form av kliniska tjänster och motsvarande rådgivning samt utbildning. Dessutom ska bolaget bedriva handel med medicinsk och annan teknisk utrustning och därmed förenlig verksamhet. Bolaget ska även bedriva förvaltning av aktier, andra värdepapper och fastigheter.
Address
Kvistrumsvägen 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 122 | 186 | 996 | 23 | 16 |
| Staff expenses | — | — | −275 | −0 | −0 |
| EBITDA | 88 | 138 | 632 | −37 | −60 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 88 | 138 | 632 | −37 | −60 |
| Net financials | −3 | −0 | 119 | −1 | −8 |
| Profit before tax | 63 | 138 | 752 | −7 | 22 |
| Tax | −14 | −29 | −157 | — | −14 |
| Net profit | 49 | 110 | 595 | −7 | 8 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 479 | 593 | 1 211 | 973 | 758 |
| Equity | 248 | 357 | 769 | 680 | 688 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 88 | 93 | 299 | 182 | 47 |
| Total debt | 88 | 93 | 299 | 182 | 47 |
EBITDA margin
-372.2%
This company
15.8%
Market median
-2456% vs market
20212025
Equity ratio
90.8%
This company
38.2%
Market median
+138% vs market
20212025
Return on equity
1.2%
This company
18.4%
Market median
-93% vs market
20212025
Net profit margin
52.8%
This company
8.1%
Market median
+552% vs market
20212025
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20212025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Augmedica Nordic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gustaf Lars Erik Pettersson | Deputy Board Member | 0 companies |
| John Erik Sebastian Brauns | Board of Directors | 0 companies |